Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
GMR SOLUTIONS INC (GMRS)
NYSEIndustrialsMedical - Care FacilitiesSnapshot 2026-11-05
$12.51+0.97%
Close 2026-11-05 · 1-day change
NYSEIndustrialsMedical - Care FacilitiesSnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Oct 4, 2026.
Next-FY EPS estimate change · 30 days
1.78 → 1.78 EPS · FY ending Dec 31, 2027 · 3 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 6, 2026 to Nov 5, 2026: (new ÷ prior − 1). Contributor count changed from 4 to 3; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for GMRS yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Reduce leverage and strengthen balance sheet through debt repayment | They are reducing debt, which strengthens their balance sheet. | Intact | Fails to repay at least $200M in debt by end of 2026 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in a supplied disclosure. Management reported: ““This transaction reflects the commitments we made to utilize cash generated by the business to reduce total leverage,” said Brian Tierney, chief financial officer of GMR.” “Repricing GMR used approximately $200 million of cash on hand to repay outstanding term loan borrowings, reducing the outstanding principal amount of the facility to approximately $2.7 billion.” |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 9, 2026
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This investment represents a turnaround scenario, as GMRS is working to improve its financial performance while navigating sector challenges. The current thesis state is characterized by low confidence and insufficient recent performance history.
The market appears to have priced in a justified valuation with a low expectations gap. There is a sense of stability, but the overall sentiment remains cautious due to recent performance trends.
Management is on track to meet its revenue guidance, but adjusted EBITDA is under pressure, indicating mixed results. There is an elevated risk of missing earnings expectations in the near term, which could impact sentiment further.
The future performance of GMRS hinges on the ability to meet its financial targets and the performance of sector bellwether HCSG. Any guidance cuts or misses from HCSG could negatively affect GMRS, while positive momentum from HCSG could provide a boost.
Over the next 1 to 3 years, GMRS must navigate significant risks while attempting to stabilize its financial performance. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Achieve interest savings of $28M through debt refinancing | Interest savings from lower borrowing costs will improve profitability. | Intact | Interest savings fall below $28M in FY26 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in a supplied disclosure. Management reported: ““This transaction reflects the commitments we made to utilize cash generated by the business to reduce total leverage,” said Brian Tierney, chief financial officer of GMR.” “Repricing GMR used approximately $200 million of cash on hand to repay outstanding term loan borrowings, reducing the outstanding principal amount of the facility to approximately $2.7 billion.” Delivery assessment Nov 5, 2026 |
Achieve full-year 2026 revenue guidance of $5.89B to $6.18B | A primary condition in GMR SOLUTIONS INC's published investment case. The stated target is >=5.89B. | Intact | Revenue falls below $5.89B in FY26 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 1 of 1 supplied quarters. Management reported: “Despite this comparison dynamic, the underlying performance of our business remains strong, and we are reaffirming our full-year guidance, based on our results to date and outlook for the remainder of the year.”” ““We are pleased with our second quarter results, which reflect operational execution and continued momentum across our business,” said Nick Loporcaro, Chairman and Chief Executive Officer at GMR.” Revenue was $1.490 billion in 2026-Q2. Delivery assessment Nov 5, 2026 |
Stored thesis · Oct 4, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$1.78 → $1.78 · observed estimates
$6.36B → $6.37B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-27 | $1.78 | $6,359,246,251 | 4 / 5 |
| 2026-07-28 | $1.78 | $6,359,246,251 | 4 / 5 |
| 2026-07-29 | $1.78 | $6,359,246,251 | 4 / 5 |
| 2026-07-30 | $1.78 | $6,359,246,251 | 4 / 5 |
| 2026-07-31 | $1.81 | $6,359,246,260 | 7 / 7 |
| 2026-08-01 | $1.78 | $6,359,246,251 | 4 / 5 |
| 2026-08-02 | $1.78 | $6,359,246,251 | 4 / 5 |
| 2026-08-03 | $1.81 | $6,359,246,260 | 7 / 7 |
| 2026-08-04 | $1.81 | $6,359,246,260 | 7 / 7 |
| 2026-08-05 | $1.81 | $6,359,246,260 | 7 / 7 |
| 2026-08-06 | $1.78 | $6,359,246,251 | 4 / 5 |
| 2026-08-07 | $1.78 | $6,359,246,251 | 4 / 5 |
| 2026-08-08 | $1.81 | $6,359,246,260 | 7 / 7 |
| 2026-08-09 | $1.81 | $6,359,246,260 | 7 / 7 |
| 2026-08-10 | $1.81 | $6,359,246,260 | 7 / 7 |
| 2026-08-12 | $1.78 | $6,359,246,251 | 4 / 5 |
| 2026-08-13 | $1.78 | $6,359,246,251 | 4 / 5 |
| 2026-08-14 | $1.78 | $6,359,246,251 | 4 / 5 |
| 2026-08-15 | $1.78 | $6,359,246,251 | 4 / 5 |
| 2026-08-16 | $1.78 | $6,359,246,251 | 4 / 5 |
| 2026-08-17 | $1.78 | $6,359,246,251 | 4 / 5 |
| 2026-08-18 | $1.78 | $6,359,246,251 | 4 / 5 |
| 2026-08-19 | $1.78 | $6,359,246,251 | 4 / 5 |
| 2026-08-20 | $1.74 | $6,371,134,706 | 4 / 5 |
| 2026-08-21 | $1.74 | $6,371,134,706 | 4 / 5 |
| 2026-08-22 | $1.74 | $6,371,134,706 | 4 / 5 |
| 2026-08-23 | $1.74 | $6,371,134,706 | 4 / 5 |
| 2026-08-24 | $1.74 | $6,371,134,706 | 4 / 5 |
| 2026-08-25 | $1.74 | $6,371,134,706 | 4 / 5 |
| 2026-08-26 | $1.74 | $6,371,134,706 | 4 / 5 |
| 2026-08-27 | $1.74 | $6,371,134,706 | 4 / 5 |
| 2026-08-28 | $1.74 | $6,371,134,706 | 4 / 5 |
| 2026-08-29 | $1.74 | $6,371,134,706 | 4 / 5 |
| 2026-08-30 | $1.74 | $6,371,134,706 | 4 / 5 |
| 2026-08-31 | $1.74 | $6,371,134,706 | 4 / 5 |
| 2026-09-01 | $1.74 | $6,371,134,706 | 4 / 5 |
| 2026-09-02 | $1.74 | $6,371,134,706 | 4 / 5 |
| 2026-09-03 | $1.74 | $6,371,134,706 | 4 / 5 |
| 2026-09-04 | $1.74 | $6,371,134,706 | 4 / 5 |
| 2026-09-05 | $1.74 | $6,371,134,706 | 4 / 5 |
| 2026-09-06 | $1.74 | $6,371,134,706 | 4 / 5 |
| 2026-09-07 | $1.74 | $6,371,134,706 | 4 / 5 |
| 2026-09-08 | $1.74 | $6,371,134,706 | 4 / 5 |
| 2026-09-09 | $1.74 | $6,371,134,706 | 4 / 5 |
| 2026-09-10 | $1.74 | $6,371,134,706 | 4 / 5 |
| 2026-09-11 | $1.74 | $6,371,134,706 | 4 / 5 |
| 2026-09-12 | $1.77 | $6,370,420,421 | 3 / 5 |
| 2026-09-13 | $1.77 | $6,370,420,421 | 3 / 5 |
| 2026-09-14 | $1.77 | $6,370,420,421 | 3 / 5 |
| 2026-09-15 | $1.77 | $6,370,420,421 | 3 / 5 |
| 2026-09-16 | $1.77 | $6,370,420,421 | 4 / 5 |
| 2026-09-17 | $1.77 | $6,370,420,421 | 4 / 5 |
| 2026-09-18 | $1.77 | $6,370,420,421 | 4 / 5 |
| 2026-09-19 | $1.77 | $6,370,420,421 | 4 / 5 |
| 2026-09-20 | $1.77 | $6,370,420,421 | 4 / 5 |
| 2026-09-21 | $1.77 | $6,370,420,421 | 4 / 5 |
| 2026-09-22 | $1.77 | $6,370,420,421 | 4 / 5 |
| 2026-09-23 | $1.77 | $6,370,420,421 | 4 / 5 |
| 2026-09-24 | $1.77 | $6,370,420,421 | 4 / 5 |
| 2026-09-25 | $1.77 | $6,370,420,421 | 4 / 5 |
| 2026-09-26 | $1.77 | $6,370,420,421 | 4 / 5 |
| 2026-09-27 | $1.77 | $6,370,420,421 | 4 / 5 |
| 2026-09-28 | $1.77 | $6,370,420,421 | 4 / 5 |
| 2026-09-29 | $1.77 | $6,370,420,421 | 4 / 5 |
| 2026-09-30 | $1.77 | $6,370,420,421 | 4 / 5 |
| 2026-10-01 | $1.77 | $6,370,420,421 | 4 / 5 |
| 2026-10-02 | $1.77 | $6,370,420,421 | 4 / 5 |
| 2026-10-03 | $1.77 | $6,370,420,421 | 4 / 5 |
| 2026-10-04 | $1.77 | $6,370,420,421 | 4 / 5 |
| 2026-10-05 | $1.77 | $6,370,420,421 | 4 / 5 |
| 2026-10-06 | $1.78 | $6,370,420,421 | 4 / 5 |
| 2026-10-07 | $1.78 | $6,370,420,421 | 4 / 5 |
| 2026-10-08 | $1.78 | $6,370,420,421 | 4 / 5 |
| 2026-10-09 | $1.78 | $6,370,420,421 | 4 / 5 |
| 2026-10-10 | $1.78 | $6,370,420,421 | 4 / 5 |
| 2026-10-11 | $1.78 | $6,370,420,421 | 4 / 5 |
| 2026-10-12 | $1.78 | $6,370,420,421 | 4 / 5 |
| 2026-10-13 | $1.78 | $6,370,420,421 | 4 / 5 |
| 2026-10-14 | $1.78 | $6,370,420,421 | 3 / 5 |
| 2026-10-15 | $1.78 | $6,370,420,421 | 3 / 5 |
| 2026-10-16 | $1.78 | $6,370,420,421 | 3 / 5 |
| 2026-10-17 | $1.78 | $6,370,420,421 | 3 / 5 |
| 2026-10-18 | $1.78 | $6,370,420,421 | 3 / 5 |
| 2026-10-19 | $1.78 | $6,370,420,421 | 3 / 5 |
| 2026-10-20 | $1.78 | $6,370,420,421 | 3 / 5 |
| 2026-10-21 | $1.78 | $6,370,420,421 | 3 / 5 |
| 2026-10-22 | $1.78 | $6,370,420,421 | 3 / 5 |
| 2026-10-23 | $1.78 | $6,370,420,421 | 3 / 5 |
| 2026-10-24 | $1.78 | $6,370,420,421 | 3 / 5 |
| 2026-10-25 | $1.78 | $6,370,420,421 | 3 / 5 |
| 2026-10-26 | $1.78 | $6,370,420,421 | 3 / 5 |
| 2026-10-27 | $1.78 | $6,370,420,421 | 3 / 5 |
| 2026-10-28 | $1.78 | $6,370,420,421 | 3 / 5 |
| 2026-10-29 | $1.78 | $6,370,420,421 | 3 / 5 |
| 2026-10-30 | $1.78 | $6,370,420,421 | 3 / 5 |
| 2026-10-31 | $1.78 | $6,370,420,421 | 3 / 5 |
| 2026-11-01 | $1.78 | $6,370,420,421 | 3 / 5 |
| 2026-11-02 | $1.78 | $6,370,420,421 | 3 / 5 |
| 2026-11-03 | $1.78 | $6,370,420,421 | 3 / 5 |
| 2026-11-04 | $1.78 | $6,370,420,421 | 3 / 5 |
| 2026-11-05 | $1.78 | $6,370,420,421 | 3 / 5 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 7 Buy / Strong Buy · 1 Hold · 0 Sell / Strong Sell
Recent actions · Oct 7–Nov 5 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.